You just read:

Foresee Pharmaceuticals Announces Top-Line Results from Phase 3 Registration Study in Advanced Prostate Cancer

News provided by

Foresee Pharmaceuticals Co., Ltd.

27 Jan, 2017, 02:40 GMT